bms-906024 bms-906024 bms-906024 is a drug with a benzodiazepine structure, developed by bristol-myers squibb and disclosed at the spring 2013 american chemical society meeting in new orleans to treat breast, lung, colon cancers and leukemia. the drug works as a pan-notch inhibitor. the structure is one of a set patented in 2012, and is being studied in clinical trials. bms-906024identifiers iupac name (2r,3s)-n--2,3-bis(3,3,3-trifluoropropyl)succinamide cas number1401066-79-2pubchem cid66550890pubchem sid152143555chemspider28536138uniidrl23n424rcomptox dashboard (epa)dtxsid30161234 chemical and physical dataformulac26h26f6n4o3molar mass556.509 g·mol−13d model (jsmol)interactive image smiles cn1c2ccccc2c(=n(c1=o)nc(=o)(ccc(f)(f)f)(ccc(f)(f)f)c(=o)n)c3ccccc3 inchi inchi=1s/c26h26f6n4o3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22h,11-14h2,1h3,(h2,33,37)(h,35,38)/t16-,17+,22+/m0/s1key:ayouddaetnmcbw-gshuggbrsa-n